Tweets

February 22

A familiar story ... https://t.co/FFRjzM2piB

February 21

In depth analysis of the recent CRISPR decision - and why this is a story that is probably not yet over. https://t.co/ea2uMZFT2S

February 21

Recent PTAB decision over revolutionary #CRISPR technology could presage more #patent battles https://t.co/ea2uMZFT2S

Blog

21 Feb 2017
PTAB issues key decision over revolutionary CRISPR technology, but this tale is not over yet

The gene-editing tool CRISPR is in the process of transforming the life sciences industry. Perhaps not surprisingly with such a revolutionary technology still in its relative infancy, a dispute over patents between universities and research institutes that have been at the forefront of its development, erupted over just who owns some of the foundational IP. Last week in a closely watched...

21 Feb 2017
With one eye on the Asian market, Microsoft lends regional partners a helping hand in Philips suits

Microsoft recently filed a petition for inter partes review of a patent owned by Philips – one that is among several that the Dutch company is currently asserting in US district court against a number of Chinese, Taiwanese and US manufacturers.  As reported by Steve Brachmann over at the IP Watchdog blog yesterday, Microsoft filed a petition with the USPTO’s Patent Trials...

20 Feb 2017
Landmark multi-year patent battle in China ends with foreign biotech innovator coming out on top

In what it hailed as a “landmark” biotech patent validity case, Danish company Novozymes has won out in  a six year patent fight with major Chinese competitors following a judgment from the Supreme People’s Court. The result is important because Novozymes has said that some of the patentability requirements in its technology area are harder to meet in China compared...

Explore the current issue

Why smart corporate IP strategies need licence on transfer

Licence on transfer is an emerging and flexible licensing tool which should be a part of every corporate IP transactions strategy
James Kovacs and Nader Mousavi

The world's leading patent professionals

IAM Patent 1000

The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.

Visit site

The world's leading IP strategists

IAM Strategy 300

A directory of individuals identified following a detailed research process as global leaders in providing IP value creation expertise to rights owners.

Visit site
IAM Market
Market intelligence

Market intelligence

Annual IAM supplements and management reports that take an in-depth look at specific areas of IP value creation concern and opportunity.

Visit site
IPBC

IPBC

Unique in the global IP marketplace, IPBC events bring together corporate leaders, aggregators, investors and other intermediaries to discuss key issues, network and do deals.

Visit site
IP Hall of Fame

IP Hall of Fame

A project designed to recognise the outstanding contributions that individual men and women have made towards the creation of today’s global IP system.

Visit site
Upcoming event

Upcoming event

The IP Software Summit 2017
May 18 2017 - San Francisco, United States
 The first event to discuss open innovation, open source and proprietary systems, the scope of patent protection and more. 

View all events
Subscribe

Subscribe

IAM is a unique publication which focuses on the many ways in which intellectual property and intangible assets can be used to create corporate value.

Subscribe now
International reports

International reports

Weekly updates from IAM’s team of international correspondents looking at recent developments in IP law and practice, business and finance.

Visit site